Orgenesis (45O0) Stock Statistics & Valuation Metrics
Total Valuation
Orgenesis has a market cap or net worth of EUR 246.12K. The enterprise value is EUR 37.17M.
- Market Cap
- EUR 246.12K
- Enterprise Value
- EUR 37.17M
Share Statistics
Orgenesis has 9,799,538 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 9,799,538
- Owned by Insiders
- ―
- Owned by Institutions
- 0.06%
Financial Efficiency
Orgenesis’s return on equity (ROE) is 2.64 and return on invested capital (ROIC) is -3156.92%.
- Return on Equity (ROE)
- 2.64
- Return on Assets (ROA)
- -3.80
- Return on Invested Capital (ROIC)
- -3156.92%
- Return on Capital Employed (ROCE)
- 28.91
- Revenue Per Employee
- 6,883.117
- Profits Per Employee
- -718.97K
- Employee Count
- 77
- Asset Turnover
- 0.04
- Inventory Turnover
- 183.97
Valuation Ratios
The current PE Ratio of Orgenesis is -0.01. Orgenesis’s PEG ratio is 0.00.
- PE Ratio
- -0.01
- PS Ratio
- 0.52
- PB Ratio
- -0.04
- Price to FCF
- -0.02
- Price to Operating Cash Flow
- -0.05
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Orgenesis had revenue of 530.00K and earned -55.36M in profits. Earnings per share was -1.91.
- Revenue
- 530.00K
- Gross Profit
- -5.72M
- Operating Income
- -53.64M
- Pretax Income
- -64.44M
- Net Income
- -55.36M
- EBITDA
- -60.72M
- Earnings Per Share (EPS)
- -1.91
Cash Flow
In the last 12 months, operating cash flow was -15.48M and capital expenditures -318,000, giving a free cash flow of -15.80M billion.
- Operating Cash Flow
- -15.48M
- Free Cash Flow
- -15.80M
- Free Cash Flow per Share
- -0.58
Dividends & Yields
Orgenesis pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -6160.21%
- Earnings Yield
- -6803.86%
Stock Price Statistics
- Beta
- ―
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 3.60
- 200-Day Moving Average
- 3.60
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Orgenesis upcoming earnings date is ―, TBA (Not Confirmed).
- Last Earnings Date
- Nov 07, 2025
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Orgenesis as a current ratio of 0.25, with Debt / Equity ratio of -107.81%
- Current Ratio
- 0.25
- Quick Ratio
- 0.25
- Debt to Market Cap
- 0.15
- Net Debt to EBITDA
- -0.36
- Interest Coverage Ratio
- -24.75
Taxes
In the past 12 months, Orgenesis has paid 473.00K in taxes.
- Income Tax
- 473.00K
- Effective Tax Rate
- -0.01
Enterprise Valuation
Orgenesis EV to EBITDA ratio is -0.36, with an EV/FCF ratio of -1.30.
- EV to Sales
- 41.62
- EV to EBITDA
- -0.36
- EV to Free Cash Flow
- -1.30
- EV to Operating Cash Flow
- -1.49
Balance Sheet
Orgenesis has EUR 204.00K in cash and marketable securities with EUR 17.30M in debt, giving a net cash position of -EUR 17.09M billion.
- Cash & Marketable Securities
- EUR 204.00K
- Total Debt
- EUR 17.30M
- Net Cash
- -EUR 17.09M
- Net Cash Per Share
- -EUR 1.74
- Tangible Book Value Per Share
- -EUR 0.71
Margins
Gross margin is -1080.19%, with operating margin of -10120.00%, and net profit margin of -10445.47%.
- Gross Margin
- -1080.19%
- Operating Margin
- -10120.00%
- Pretax Margin
- -12159.43%
- Net Profit Margin
- -10445.47%
- EBITDA Margin
- -11456.23%
- EBIT Margin
- -11750.57%
